No Data
No Data
The 6.2% Return This Week Takes Prestige Consumer Healthcare's (NYSE:PBH) Shareholders Five-year Gains to 92%
Some Confidence Is Lacking In Prestige Consumer Healthcare Inc.'s (NYSE:PBH) P/S
Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $87
Prestige Consumer Healthcare Inc. to Announce Fiscal 2025 Third Quarter Earnings on February 6, 2025
Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $93